GULP1 and hepatocellular carcinoma: The expression levels of <i>EV-GULP1</i> were quantified using quantitative reverse transcription polymerase chain reaction (qRT-PCR).<h4>Results</h4><i>EV-GULP1</i> expression was found to be significantly higher in HCC patients, including those with early-stage disease, when compared to control groups.